| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 05/15/2002 | EP1204742A2 Oligonucleotides for inhibiting the expression of human eg5 |
| 05/15/2002 | EP1204741A2 Simultaneous isolation and quantitation of dna |
| 05/15/2002 | EP1204740A1 Methods and compositions for directed cloning and subcloning using homologous recombination |
| 05/15/2002 | EP1204739A2 Enhancement of expression of a single-stranded, heterologous nucleotide sequence from recombinant viral vectors by designing the sequence such that it forms intrastrand base pairs |
| 05/15/2002 | EP1204738A1 A method for decreasing the foam formation during cultivation of a microorganism |
| 05/15/2002 | EP1204683A1 Ovarian cancer cell and myeloma cell surface glycoproteins, antibodies thereto, and uses thereof |
| 05/15/2002 | EP1204682A2 Compositions and methods for the treatment of tumors |
| 05/15/2002 | EP1204681A2 Helical cytokine zalpha48 |
| 05/15/2002 | EP1204678A1 Moraxella cattarrhalis basb114 antigens and uses thereof |
| 05/15/2002 | EP1204674A2 Methods and compositions for inhibiting polypeptide accumulation associated with neurological disorders |
| 05/15/2002 | EP1204672A1 High affinity vascular endothelial growth factor (vegf) receptor nucleic acid ligands and inhibitors |
| 05/15/2002 | EP1204479A1 Multiple fluid sample processor and system |
| 05/15/2002 | EP1204430A2 Conjugates and methods for the production thereof, and their use for transporting molecules via biological membranes |
| 05/15/2002 | EP1204428A2 Targeted lipid particles |
| 05/15/2002 | EP1204424A1 Recombinant rsv virus expression systems and vaccines |
| 05/15/2002 | EP1204422A2 Stress-proteins from extra-cellular pathogens as vaccines against infectious agents |
| 05/15/2002 | EP1204321A2 Super-active porcine growth hormone releasing hormone analog |
| 05/15/2002 | EP1147186A4 In vitro activated gamma delta lymphocytes |
| 05/15/2002 | EP1124723A4 Fuel nozzle dispenser using ultrasonic metering |
| 05/15/2002 | EP1096941A4 Bone marrow cells as a source of neurons for brain and spinal cord repair |
| 05/15/2002 | EP1071812A4 A method, reagent solution and kits for dna sequencing |
| 05/15/2002 | EP0900285A4 Technique for representing combinatorial chemistry libraries resulting from selective combination of synthons |
| 05/15/2002 | EP0833900A4 Method of making herpes simplex type 1 mutants and mutants so produced |
| 05/15/2002 | EP0832287A4 Oligonucleotide tags for sorting and identification |
| 05/15/2002 | EP0633941B1 Synthetic eukaryotic promoters containing two inducible elements |
| 05/15/2002 | CN1349560A Avermectin aglycon synthase genes |
| 05/15/2002 | CN1349559A Noninvasive detection of colorectal cancer and other gasrointestinal pathology |
| 05/15/2002 | CN1349543A Membrane disruptive peptides covalently oligomerized |
| 05/15/2002 | CN1349541A L-ribo-LNA analogues |
| 05/15/2002 | CN1348962A Rice pollen fertility controlling gene and its usage |
| 05/15/2002 | CN1084791C Process for production of 7-ADCA via expandase activity on penicillin G |
| 05/15/2002 | CN1084598C Frozen confectionery products |
| 05/14/2002 | US6388175 Nucleotide and amino acid sequence of albicidin detoxification enzyme; for transgenic plants with disease resistance |
| 05/14/2002 | US6388174 Gene encoding α-subunit of rice anthranilate synthase and DNA relating thereto |
| 05/14/2002 | US6388173 Scarecrow promotor and uses thereof |
| 05/14/2002 | US6388172 Phytochrome regulated transcription factor for control of higher plant development |
| 05/14/2002 | US6388171 Host cell with stably incorporated expression cassette of promoter and specific nucleotide sequence; improved food grain quality |
| 05/14/2002 | US6388170 Bidirectional promoters and methods related thereto |
| 05/14/2002 | US6388169 Maize orthologues of bacterial RecA proteins |
| 05/14/2002 | US6388168 Expression cassette includes 5' regulatory sequence for controlling expression, 3' regulatory sequence for stable mrna, and a cloning segment for insertion of a coding segment |
| 05/14/2002 | US6388099 Heterologous expression of a recombinant gene encoding a p450 monoxygenase in a host cell, e.g. streptomyces lividans, to produce 8,8a-deoxyoleandolide, an aglycone precursor of oleandomycin |
| 05/14/2002 | US6388068 Nucleotide sequences of promoters; for efficient industrial production of exogenous polypeptides in plant xylem sap |
| 05/14/2002 | US6388067 Nucleotide sequence; for transgenic plants |
| 05/14/2002 | US6388066 MAR/SAR elements flanking RSYN7-driven construct |
| 05/14/2002 | US6388065 DNA for evaluating the progression potential of cervical lesions |
| 05/14/2002 | US6388064 Human 2-19 protein homologue, z219a |
| 05/14/2002 | US6388056 Inhibition of transglutaminase-mediated microbial interaction with a mammalian host |
| 05/14/2002 | US6388055 Mouse CC-CKR5 receptor polypeptide |
| 05/14/2002 | US6388052 Amino acid sequence of nuclear factor of activated t lymphocytes, a transcription factor; immunomodulators |
| 05/14/2002 | US6387875 Method of use for murine leukaemia inhibitory factor-binding protein (mLBP) |
| 05/14/2002 | US6387703 Selecting polynucleotide binding agent site and binding agent, contacting organism with site and agent, then detecting change in gene expression |
| 05/14/2002 | US6387702 Recombining dna segments of competence genes to create library, screening library for improved competence in non-mammalian cells, repeating until desired level achieved, then transforming into cell |
| 05/14/2002 | US6387701 Method of identifying tumor antigens that elicit a T-cell response |
| 05/14/2002 | US6387700 Binding tryptophan-containing peptide to nucleic acid to make complex, then introducing complex to cell so that it is delivered across the cell membrane |
| 05/14/2002 | US6387699 Antisense inhibition of A20 expression |
| 05/14/2002 | US6387698 Polyclonal antiserum produced by immunzing animal with tumor rejection antigen precursor |
| 05/14/2002 | US6387690 Endoglucanases |
| 05/14/2002 | US6387688 Coriolus hirsutus host cell transformed with vector containing specific promoter; degradation of lignin in wood pulp |
| 05/14/2002 | US6387686 Detecting nucleotide sequences which code cell surface protease; incubate target cells with viral display packages and detect signal from transformed cells |
| 05/14/2002 | US6387685 Recombinant equine herpes virus having gene 12 deleted; replication-deficient vectors for gene therapy and vaccines |
| 05/14/2002 | US6387683 Recombinant yeast PDI and process for production thereof |
| 05/14/2002 | US6387682 Amino acid sequence of polypeptide with cysteine protease activity; treatment of bone disorders such as osteoporosis; anticarcinogenic agents; antitumor agents; antimetastasis agents |
| 05/14/2002 | US6387681 Method for cloning and expression of NHEI restriction endonuclease in E. coli. |
| 05/14/2002 | US6387676 Human cDNAs encoding polypeptides having kinase functions |
| 05/14/2002 | US6387675 Amino acid sequences of synthetic mutant beetle enzyme; for use in biosensors and as reporter molecules |
| 05/14/2002 | US6387674 Has activity against betal amyloid 1-42 protein in beta sheet conformation; treatment of alzheimer's disease amyloidosis, atherosclerosis, and creutzfeld-jakob disease |
| 05/14/2002 | US6387673 Anticarcinogenic agent composed of ligand for steroid/thyroid hormone superfamily of receptors, histone deacetylase inhibitor which interacts with receptor, and pharmaceutically acceptable carrier |
| 05/14/2002 | US6387671 Sending electrical current from one point to another point through electroconductive tissue, creating image of tissue, adjusting an electrical parameter for desired degree of electroporation |
| 05/14/2002 | US6387670 Method for producing recombinant virus |
| 05/14/2002 | US6387668 Crude or pure enzyme preparation from agrobacterium species; for selectively degrading epichlorohydrin |
| 05/14/2002 | US6387667 Using recombinant microorganism cultures which produce specific enzymes and orotic acid and choline as starting materials |
| 05/14/2002 | US6387665 Using protective antigens; genetic engineering |
| 05/14/2002 | US6387664 Fusion protein of defined amino acid sequence and which inhibits neuron adhesion to plastic; includes secreted protein acidic and rich in cysteine; treatment of nervous system disorders |
| 05/14/2002 | US6387663 Fusion protein of collagen binding domain and angiogenesis modulating domain; treatment of cardiovascular disorders; antiischemic agents |
| 05/14/2002 | US6387662 Constructing recombinant dna encoding core protein, envelope 1 protein, and envelope 2 protein; expressing dna in eukaryotic host cell and allowing assembly; then isolating non-infectious particle |
| 05/14/2002 | US6387661 Nucleic acid molecules encoding human aminoacylase proteins |
| 05/14/2002 | US6387658 PCNA-associated cell cycle proteins, compositions and methods of use |
| 05/14/2002 | US6387657 Amino acid sequence of wnt-1-induced secreted protein; anticarcinogenic agents; antitumor agents; treatment of arteriosclerosis; diagnosis of related disorders |
| 05/14/2002 | US6387655 Excitatory amino acid receptor protein and related nucleic acid compounds |
| 05/14/2002 | US6387643 Amino acid sequence; antiinflammatory agents; antiarthritic agents; anticarcinogenic agents |
| 05/14/2002 | US6387639 Ma family polypeptides and anti-Ma antibodies |
| 05/14/2002 | US6387638 Heregulin variants |
| 05/14/2002 | US6387635 2′-fluoropyrimidine anti-calf intestinal phosphatase nucleic acid ligands |
| 05/14/2002 | US6387633 Transfecting cells with vector expressing human mts-1, selecting cells that express mts-1, subcloning those cells, comparing phenotypes, determining correlation coefficient for each gene in a gene panel, then identifying unstable gene |
| 05/14/2002 | US6387631 Silylating a support, e.g. glass, with an aminoalkylsilane silane-triol or -trihalide; activating with a crosslinker; reacting with an amine-containing polymer and attaching target biomolecules in a defined way; stability; gene mapping |
| 05/14/2002 | US6387629 Use of cathepsin S in the diagnosis and treatment of endometriosis |
| 05/14/2002 | US6387627 Phagemid for antibody screening |
| 05/14/2002 | US6387626 Covalent attachment of unmodified nucleic acids to silanized solid phase surfaces |
| 05/14/2002 | US6387624 Construction of uni-directionally cloned cDNA libraries from messenger RNA for improved 3′ end DNA sequencing |
| 05/14/2002 | US6387621 Automated analysis of real-time nucleic acid amplification |
| 05/14/2002 | US6387620 Transcription-free selex |
| 05/14/2002 | US6387619 Telomerase compositions and methods |
| 05/14/2002 | US6387617 Proto-nucleozyme having catalytic activity in presence of non-nucleic cofactor which chemically interacts to provide missing component; viricides; anticarcinogenic agents |
| 05/14/2002 | US6387616 Torsin, torsin genes, and methods of use |
| 05/14/2002 | US6387396 In gene therapy and in in vitro and in vivo transfection |
| 05/14/2002 | US6387395 N-[1, (1-1) -dialkyloxy] - and N- [1, (1-1) -dialkenyloxy]- alk-1-yl-N,N,N-tetrasubstituted ammonium lipids and uses therefor |
| 05/14/2002 | US6387377 Acellular antibordetella vaccine |
| 05/14/2002 | US6387376 Recombinant vaccine containing feline herpes virus type 1 particularly for treating feline infectious peritonitis |
| 05/14/2002 | US6387372 Polypeptides from mycrobacterium paratuberculosis |
| 05/14/2002 | US6387371 Specifically binds to an extracellular domain of the her2 receptor in an amount effective to inhibit growth of cancer cells |